Central Pennsylvania Hematology and Medical Oncology Associates, PC

Lemoyne, Pennsylvania 17043

0 studies enrolling now · 12 studies all time

What they study most

Bladder Cancer, Extensive Stage Small Cell Lung Cancer, Kidney Cancer, Leukemia, Lung Cancer, Lymphoma, Melanoma (Skin), Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer

Studies at this site

• Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma — Completed
• Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma — Completed
• Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia — Stopped early
• Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
• Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer — Completed
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium — Completed
• Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer — Completed
• Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms — Completed
• Combination Chemotherapy in Treating Patients With Bladder Cancer — Completed
• Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) — Completed
• S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma — Completed
• Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer — Withdrawn before enrolling